The Evaluation of PMP22 and Protein 0, Examinations for Early Disability Detection in Leprosy Patients

• Main Authors: Dhelya Widasmara, -, Indropo Agusni, -, Agus Turchan, Agus, Sri Linuwih M, -
• Format: Article PeerReviewed
• Language: English; English; English; Indonesian
• Published: Hiroshima University Medical Press 2018
• Subjects: R Medicine (General); R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/94186/1/07%20-%20The%20Evaluation%20of%20PMP22%20and%20Protein%200%2C%20Examinations%20for%20Early%20Disability%20Detection%20in%20Leprosy%20Patients.pdf; https://repository.unair.ac.id/94186/2/The%20evaluationof%20PMP22%20and%20Protein%20.pdf; https://repository.unair.ac.id/94186/3/2018%20-%20The%20Evaluation%20of%20PMP22%20.%20.%20.%20Hiroshima%20Journal%20of%20med%20sc.pdf; https://repository.unair.ac.id/94186/7/6A_Karil.pdf; https://repository.unair.ac.id/94186/; https://ir.lib.hiroshima-u.ac.jp/en/list/HU_journals/AA00664312/67/--/item/45862
• Institution: Universitas Airlangga

Introduction: Leprosy is a chronic infectious disease caused by Mycobacterium leprae that has a predilection for peripheral nerves, especially Schwann cells. Leprosy medications may only eradicate the bacteria without preventing or recovering peripheral nerve damage. Previous studies proved that Kro...